NCT02970617

Brief Summary

This clinical trial studies how well ringing a bell on the final day of radiation therapy works in improving the memory of distress in cancer patients. Ringing a bell on the final day of radiation therapy may improve the memory of how painful the treatment was.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
82

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 15, 2016

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 15, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 22, 2016

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2018

Completed
Last Updated

October 7, 2025

Status Verified

April 1, 2020

Enrollment Period

2.3 years

First QC Date

November 15, 2016

Last Update Submit

October 2, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Distress memory scales as assessed by the 11-point Numeric Rating Scale

    Patient baseline characteristics and treatment will be summarized in groups A and B. Repeated measures analysis of variance (ANOVA) will be used to compare distress memory scales between patients in group A and group B. A mixed regression model will be used to examine the effect of ringing the bell on the last day of radiotherapy on distress memory scales when considering covariates such as baseline patient characteristics, cancer type, radiotherapy total dose and duration, baseline distress scale, analgesic medication, disease recurrence status, optimism/pessimism personality and anxiety.

    Up to 7 months

Secondary Outcomes (2)

  • Anxiety level as assessed by Generalized Anxiety Disorder 7 scale

    Up to 7 months

  • Optimism-pessimism scores as assessed by the Life Orientation Test-Revised

    Up to 7 months

Study Arms (2)

Group A (no bell after final radiation)

ACTIVE COMPARATOR

Patients undergo standard of care radiation therapy with or without chemotherapy.

Other: Questionnaire Administration

Group B (ring bell after final radiation treatment)

EXPERIMENTAL

On the final day of standard of care radiation therapy, patients ring a bell in the clinic.

Other: Memory InterventionOther: Questionnaire Administration

Interventions

Ring bell after final radiation treatment

Group B (ring bell after final radiation treatment)

Ancillary studies

Group A (no bell after final radiation)Group B (ring bell after final radiation treatment)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of cancer
  • Definitive radiation treatment with or without concurrent chemotherapy with curative intent; treatment prior to radiation therapy is acceptable (e.g. surgery, chemotherapy)
  • Ability to understand and the willingness to sign a written informed consent; consents will be provided in English or Spanish
  • Able to speak English or Spanish (questionnaires will be in English and Spanish)

You may not qualify if:

  • Patients with either a malignant central nervous system (CNS)-primary cancer or with brain metastases; patients do not need to undergo brain imaging unless indicated per standard workup and management (e.g. advanced stage lung cancer receiving definitive therapy)
  • Patients who will be receiving surgery or adjuvant chemotherapy within 1 month following radiation treatment
  • Patients with widespread metastatic disease (\> 3 distant metastases); patients with oligometastatic disease (=\< 3 distant metastases) are allowed only if they are receiving definitive (curative) radiation therapy (RT) with or without chemotherapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

USC / Norris Comprehensive Cancer Center

Los Angeles, California, 90033, United States

Location

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Patrick Williams

    University of Southern California

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 15, 2016

First Posted

November 22, 2016

Study Start

August 15, 2016

Primary Completion

November 15, 2018

Study Completion

November 15, 2018

Last Updated

October 7, 2025

Record last verified: 2020-04

Locations